| 000 | 01616 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513185443.0 | ||
| 264 | 0 | _c19990902 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a1148-5493 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShatrov, V A | |
| 245 | 0 | 0 |
_aMethyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathway. _h[electronic resource] |
| 260 |
_bEuropean cytokine network _cJun 1999 |
||
| 300 |
_a247-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
| 650 | 0 | 4 |
_aAmino Acid Chloromethyl Ketones _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aArabidopsis Proteins |
| 650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCeramides _xphysiology |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 |
_aFatty Acid Desaturases _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xpharmacology |
| 650 | 0 | 4 |
_aS-Adenosylhomocysteine _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtoxicity |
| 700 | 1 | _aAmeyar, M | |
| 700 | 1 | _aCai, Z | |
| 700 | 1 | _aBettaieb, A | |
| 700 | 1 | _aChouaib, S | |
| 773 | 0 |
_tEuropean cytokine network _gvol. 10 _gno. 2 _gp. 247-52 |
|
| 999 |
_c10359072 _d10359072 |
||